About VirtualScopics
VirtualScopics is a Healthcare company based in Rochester (United States) founded in 2000, and was acquired by BioTelemetry in March 2016. It operates as an imaging-based clinical trial solutions are provided for disease detection. VirtualScopics has raised $3.8 million across 6 funding rounds from investors including GE Healthcare, HHS and BioTelemetry. VirtualScopics offers products and services including ECG Solutions, MCOT, ePatch, Implantable Device Monitoring, and Telehealth. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Image Analysis. Its legal entity is VIRTUALSCOPICS, INC. Its competitors include AIdoc, Median, AI Medical Service, eCential Robotics and Lantheus and 4 more; 8 of its 9 listed competitors have raised funding.
Company details
Provider of imaging-based clinical trial solutions. The company uses a collaborative approach to optimize imaging solutions, and provide quantitative imaging data that help detect disease progression faster and identify therapeutic benefits sooner. Claim to deliver highly reproducible imaging analysis. Key therapeutic areas served include Oncology, Hematology, Muscular Disease, Metabolic Disorders, and Neuroscience across imaging modalities like CT, MRI, MRE, DXA, X-ray, PET, and Ultrasound.
- Headquarters Rochester, United States
- Stage Acquired
- SectorsHealthcare
- Website virtualscopics.com
- Social LinkedIn YouTube
- Acquired by BioTelemetry (Mar 2016)
- Legal Name Virtualscopics, Inc.
- Total Equity Funding$3.8M (USD)
in 6 rounds
- Latest Funding Round$3M (USD), Post-IPO
Apr 2012
- InvestorsGE Healthcare
& 4 more
- Acquired byBioTelemetry
(Mar 2016)
Products & Services of VirtualScopics
VirtualScopics offers a comprehensive portfolio of products and services, including ECG Solutions, MCOT, ePatch, Implantable Device Monitoring, and Telehealth.
System for electrocardiogram monitoring and diagnostics.
Mobile service for outpatient cardiac telemetry.
Wearable patch for continuous heart monitoring.
System for tracking implanted medical devices.
Platform for virtual patient health support.
Apps and channels of VirtualScopics
VirtualScopics publishes 1 mobile app; its YouTube channel Philips Ambulatory Monitoring and Diagnostics has 1.84K subscribers and 30 videos.
Videos from VirtualScopics
The most watched videos on VirtualScopics's YouTube channel, Philips Ambulatory Monitoring and Diagnostics (1.84K subscribers). Click a video to play it here.
Funding Insights of VirtualScopics
VirtualScopics has successfully raised a total of $3.8M across 6 strategic funding rounds. The most recent funding activity was a Post-IPO round of $3 million completed in April 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.8M
- Total Rounds 6
- Last Round Post-IPO — $3M
- First Round $3.8M
(Feb 2003)
- Investors Count 4
All 6 funding rounds of VirtualScopics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2012 | $3M | Post-IPO | – | – | |
| Sep 2009 | $224,131 | Grant | – | – | |
| Sep 2009 | $224,131 | Grant | – | – | |
| Jun 2007 | $4.35M | Post-IPO | – | – | – |
| Nov 2005 | $4.08M | Post-IPO | – | – | – |
| Feb 2003 | $3.8M | Series C | – | – |
5 investors in total: 5 institutional.
Investors in VirtualScopics
VirtualScopics has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include GE Healthcare, HHS and BioTelemetry.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Corporate-backed venture capital is focused on the life science sector. | – | merckghifund.com | Kenilworth, United States | |
- | – | trillium-group.com | - | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
Materials management solutions are provided for healthcare organizations. | 1892 | gehealthcare.com | Chicago, United States | |
Wireless products for monitoring health parameters are offered. | 1994 | gobio.com | Malvern, United States |
Investor details for VirtualScopics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of VirtualScopics
5 dated milestones of VirtualScopics across 16 years, from founding to its latest funding, stage changes and deals.
- Founded VirtualScopics is founded.
- Funding First funding round of $3.8M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $3.0M.
- Exit Acquired by BioTelemetry.
Competitors of VirtualScopics
VirtualScopics has 9 listed competitors in our database, 8 of them funded. They include AIdoc, Median, AI Medical Service, eCential Robotics and Lantheus, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aidoc.com | 2016 | New York, United States | $424.5M | – | AI-based single-screen system is provided to streamline medical imaging. | |
| mediantechnologies.com | 2002 | Valbonne, France | $5.28M | – | Medical imaging software and services are provided for clinical trials. | |
| ai-ms.com | 2017 | Toshima, Japan | $121.9M | – | Provider of AI-based solution for diagnosis of cancer related lesions | |
| ecential-robotics.com | 2009 | Gieres, France | $133.97M | – | Robotic surgery platform for bone procedures is developed. | |
| lantheus.com | 2008 | Billerica, United States | – | 834 | Developer of diagnostic imaging agents and targeted therapeutics | |
| vista.ai | 2012 | Palo Alto, United States | $8.7M | 13 | AI-guided software is utilized to automate MRI exams for clinicians. | |
| ovizio.com | 2009 | Brussels, Belgium | $9.1M | 16 | Imaging systems and AI software for microscopes are developed. | |
| metaoptima.com | 2012 | Vancouver, Canada | $9.13M | 31 | Provider of AI-based skin cancer monitoring and detecting device for patients and doctors | |
| evidentvascular.com | 2021 | San Jose, United States | $35M | – | AI-enabled catheter-based ultrasound platforms are developed for vascular therapy. |
Detailed competitors of VirtualScopics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as VirtualScopics (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Virtualscopics
Complete news archive for VirtualScopics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VirtualScopics
VirtualScopics was founded in 2000 and raised its 1st funding round 3 years after it was founded.
VirtualScopics is headquartered in Rochester, United States.
VirtualScopics is a funded company, having raised a total of $3.8M across 6 funding rounds to date. The company's 1st funding round was a Series C of $3.8M, raised on Feb 2003.
Provider of imaging-based clinical trial solutions. The company uses a collaborative approach to optimize imaging solutions, and provide quantitative imaging data that help detect disease progression faster and identify therapeutic benefits sooner. Claim to deliver highly reproducible imaging analysis. Key therapeutic areas served include Oncology, Hematology, Muscular Disease, Metabolic Disorders, and Neuroscience across imaging modalities like CT, MRI, MRE, DXA, X-ray, PET, and Ultrasound.
VirtualScopics's top competitors include AIdoc, eCential Robotics and Vista.ai.
VirtualScopics offers ECG Solutions, MCOT, ePatch, Implantable Device Monitoring, and Telehealth.
VirtualScopics has 5 investors. Key investors include GE Healthcare, HHS, BioTelemetry, Merck Global Health Innovation Fund, and Trillium Group.
VirtualScopics operates through Virtualscopics, Inc..
Yes. VirtualScopics was acquired by BioTelemetry in March 2016.
Yes. VirtualScopics publishes Remote INR.